Drug Trial Radar · NCT05554627
VA Aripiprazole vs Esketamine for Treatment Resistant Depression
Last checked: Nov 20, 2026Latest source record: Jan 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Oct 27, 2023
Primary completion
Oct 27, 2023
Study completion Oct 27, 2023
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Sep 26, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, parallel-group, randomized clinical trial of up to 6 months treatment of adjunctive intranasal (IN) esketamine (ESK) vs. adjunctive aripiprazole (ARI) in Veterans with unipolar Treatment Resistant Depression (TRD). This study will assess the efficacy, safety, and acceptability of adjunctive IN ESK in comparison to ARI, one of the best studied and most widely used adjunctive therapies for TRD. The primary hypothesis is that participants receiving adjunctive IN ESK will be significantly more likely to achieve remission after six weeks of treatment as compared to those who receive adjunctive ARI. Depressive symptoms will be assessed by central raters (CR), blinded to treatment assignment, using the clinician rated version of the Quick Inventory of Depressive Symptomatology (QIDS-C16), a well-validated tool that is commonly used and is easily translated across other depression inventory scales. The study is powered to detect an absolute difference in remission rates of 10%, or larger, at 6 weeks. Additional outcomes of interest include symptom reduction across 6 months of randomized therapy, side effects and other tolerability indices, attrition rates and measures of quality of life and cost-effectiveness.
Conditions
- Depressive Disorder, Major
Interventions
EsketamineDrug
Intranasal spray; a dissociative hallucinogen drug used as a general anesthetic and an antidepressant for treatment of depression.
AripiprazoleDrug
Atypical antipsychotic; used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders and irritability associated with autism. Taken by mouth or injection into a muscle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quick Inventory of Depressive Symptoms (QUIDS-C16)Time frame: 6 Weeks
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Tuscaloosa VA Medical Center, Tuscaloosa, AL
Tuscaloosa, Alabama
Phoenix VA Health Care System, Phoenix, AZ
Phoenix, Arizona
Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR
Little Rock, Arkansas
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California
VA San Diego Healthcare System, San Diego, CA
San Diego, California
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut
CERC (VISN1, West Haven, CT)
West Haven, Connecticut
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Indianapolis, Indiana
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota
Kansas City VA Medical Center, Kansas City, MO
Kansas City, Missouri
New Mexico VA Health Care System, Albuquerque, NM
Albuquerque, New Mexico
Asheville VA Medical Center, Asheville, NC
Asheville, North Carolina
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
Salisbury, North Carolina
Cincinnati VA Medical Center, Cincinnati, OH
Cincinnati, Ohio
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio
Jackson C. Montgomery VA Medical Center, Muskogee, OK
Muskogee, Oklahoma
Philadelphia MultiService Center, Philadelphia, PA
Philadelphia, Pennsylvania
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas
Salem VA Medical Center, Salem, VA
Salem, Virginia
William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.